Breathe Well Live Well
|
GlaxoSmithKline Grows Theravance Stake: Investing in the Pipeline
Seeking Alpha Chief among the products of their collaboration to date is Relovair, heir to the throne of Advair, GSK's best-selling medicine for asthma attacks and COPD. … |
View full post on asthma – Google News
|
Research and Markets: Forecast Insight: Asthma/COPD – Pipeline Potential …
Business Wire (press release) This report estimates that in 2009 asthma/COPD sales reached $21.5 billion in the seven major markets. The next 10 years will see the dynamic pipeline … |
View full post on asthma – Google News